Insider Transactions in Q1 2023 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.34%
|
-
|
|
Mar 14
2023
|
Timothy C Dec Senior Vice-President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
789
-27.77%
|
$29,982
$38.65 P/Share
|
|
Mar 14
2023
|
Timothy C Dec Senior Vice-President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+34.55%
|
-
|
|
Mar 14
2023
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
SELL
Open market or private sale
|
Direct |
4,780
-50.23%
|
$167,300
$35.99 P/Share
|
|
Feb 22
2023
|
Carrolee Barlow Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,882
+22.57%
|
-
|
|
Feb 22
2023
|
Frederick M. Hudson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,882
+10.02%
|
-
|
|
Feb 22
2023
|
Georges Gemayel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,882
+22.57%
|
-
|
|
Feb 22
2023
|
John M Siebert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,882
+4.41%
|
-
|
|
Feb 22
2023
|
Charles W Newhall Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,882
+3.35%
|
-
|
|
Feb 22
2023
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
BUY
Grant, award, or other acquisition
|
Direct |
750
+7.31%
|
-
|
|
Feb 22
2023
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
750
+0.82%
|
-
|
|
Feb 22
2023
|
Timothy C Dec Senior Vice-President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
500
+27.16%
|
-
|
|
Feb 22
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
750
+18.76%
|
-
|
|
Feb 22
2023
|
Jonathan Rubin SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750
+23.1%
|
-
|
|
Feb 16
2023
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-8.42%
|
$28,614
$38.74 P/Share
|
|
Feb 16
2023
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+14.36%
|
-
|
|
Feb 16
2023
|
Jonathan Rubin SVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
-
|
|
Feb 16
2023
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+1.66%
|
-
|
|
Feb 15
2023
|
Jack A. Khattar President, CEO |
SELL
Other acquisition or disposition
|
Indirect |
8,750
-0.84%
|
-
|
|
Feb 15
2023
|
Jack A. Khattar President, CEO |
BUY
Other acquisition or disposition
|
Direct |
8,750
+1.06%
|
-
|
|
Feb 03
2023
|
Jack A. Khattar President, CEO |
BUY
Open market or private sale
|
Direct |
200
+0.02%
|
$8,400
$42.02 P/Share
|
|
Feb 03
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
330
+0.04%
|
$2,970
$9.56 P/Share
|
|
Feb 02
2023
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
13,532
-1.65%
|
$568,344
$42.05 P/Share
|
|
Feb 02
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,515
+2.68%
|
$202,635
$9.56 P/Share
|
|
Feb 01
2023
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
300
-0.04%
|
$12,600
$42.01 P/Share
|
|
Feb 01
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
498
+0.06%
|
$4,482
$9.56 P/Share
|
|
Jan 31
2023
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
976
-0.12%
|
$40,992
$42.01 P/Share
|
|
Jan 31
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,620
+0.2%
|
$14,580
$9.56 P/Share
|
|
Jan 18
2023
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
4,936
-0.62%
|
$197,440
$40.4 P/Share
|
|
Jan 18
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,080
+1.0%
|
$72,720
$9.56 P/Share
|
|
Jan 17
2023
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
25,446
-3.12%
|
$1,017,840
$40.03 P/Share
|
|
Jan 17
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,920
+4.88%
|
$377,280
$9.56 P/Share
|
|
Jan 17
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
SELL
Open market or private sale
|
Direct |
4,826
-74.59%
|
$188,214
$39.92 P/Share
|
|
Jan 17
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,826
+42.72%
|
$43,434
$9.13 P/Share
|
|
Jan 10
2023
|
Frederick M. Hudson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+21.97%
|
$61,054
$7.9 P/Share
|
|
Jan 06
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
SELL
Open market or private sale
|
Direct |
174
-9.57%
|
$6,786
$39.9 P/Share
|
|
Jan 06
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
174
+8.73%
|
$1,566
$9.13 P/Share
|